腹膜透析中连续肌酸酐排泄测量的可重复性。

Zhi Xu, Glen H Murata, Yijuan Sun, Robert H Glew, Clifford Qualls, Darlene Vigil, Karen S Servilla, Thomas A Golper, Antonios H Tzamaloukas
{"title":"腹膜透析中连续肌酸酐排泄测量的可重复性。","authors":"Zhi Xu,&nbsp;Glen H Murata,&nbsp;Yijuan Sun,&nbsp;Robert H Glew,&nbsp;Clifford Qualls,&nbsp;Darlene Vigil,&nbsp;Karen S Servilla,&nbsp;Thomas A Golper,&nbsp;Antonios H Tzamaloukas","doi":"10.5527/wjn.v6.i4.201","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To test whether muscle mass evaluated by creatinine excretion (EX<sub>Cr</sub>) is maintained in patients with end-stage kidney disease (ESKD) treated by peritoneal dialysis (PD), we evaluated repeated measurements of EX<sub>Cr</sub> in a PD population.</p><p><strong>Methods: </strong>One hundred and sixty-six PD patients (94 male, 72 female) receiving the same PD dose for the duration of the study (up to approximately 2.5 years) had repeated determinations of total (in urine plus spent dialysate) 24-h EX<sub>Cr</sub> (EX<sub>Cr</sub> T) to assess the adequacy of PD by creatinine clearance. All 166 patients had two EX<sub>Cr</sub> T determinations, 84 of the 166 patients had three EX<sub>Cr</sub> T determinations and 44 of the 166 patients had four EX<sub>Cr</sub> T measurements. EX<sub>Cr</sub> T values were compared using the paired <i>t</i> test in the patients who had two studies and by repeated measures ANOVA in those who were studied three or four times.</p><p><strong>Results: </strong>In patients who were studied twice, with the first and second EX<sub>Cr</sub> T measurements performed at 9.2 ± 15.2 mo and 17.4 ± 15.8 mo after onset of PD, respectively, EX<sub>Cr</sub> T did not differ between the first and second study. In patients studied three times and whose final assessment occurred 24.7 ± 16.3 mo after initiating PD, EX<sub>Cr</sub> T did not differ between the first and second study, but was significantly lower in the third study compared to the first study. In patients who were studied four times and whose fourth measurement was taken 31.9 ± 16.8 mo after onset of PD, EX<sub>Cr</sub> T did not differ between any of the studies. The average EX<sub>Cr</sub> T value did not change significantly, with the exception of the third study in the patients studied thrice. However, repeated determinations of EX<sub>Cr</sub> T in individuals showed substantial variability, with approximately 50% of the repeated determinations being higher or lower than the first determination by 15% or more.</p><p><strong>Conclusion: </strong>The average value of EX<sub>Cr</sub> T remains relatively constant for up to 2.5 years of follow-up in PD patients who adhere to the same PD schedule. However, repeated individual EX<sub>Cr</sub> T values vary considerably in a large proportion of the patients. Further studies are needed to evaluate the clinical significance of varying EX<sub>Cr</sub> T values and the stability of EX<sub>Cr</sub> T beyond 2.5 years of PD follow-up.</p>","PeriodicalId":23745,"journal":{"name":"World Journal of Nephrology","volume":"6 4","pages":"201-208"},"PeriodicalIF":0.0000,"publicationDate":"2017-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e6/c5/WJN-6-201.PMC5500457.pdf","citationCount":"1","resultStr":"{\"title\":\"Reproducibility of serial creatinine excretion measurements in peritoneal dialysis.\",\"authors\":\"Zhi Xu,&nbsp;Glen H Murata,&nbsp;Yijuan Sun,&nbsp;Robert H Glew,&nbsp;Clifford Qualls,&nbsp;Darlene Vigil,&nbsp;Karen S Servilla,&nbsp;Thomas A Golper,&nbsp;Antonios H Tzamaloukas\",\"doi\":\"10.5527/wjn.v6.i4.201\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aim: </strong>To test whether muscle mass evaluated by creatinine excretion (EX<sub>Cr</sub>) is maintained in patients with end-stage kidney disease (ESKD) treated by peritoneal dialysis (PD), we evaluated repeated measurements of EX<sub>Cr</sub> in a PD population.</p><p><strong>Methods: </strong>One hundred and sixty-six PD patients (94 male, 72 female) receiving the same PD dose for the duration of the study (up to approximately 2.5 years) had repeated determinations of total (in urine plus spent dialysate) 24-h EX<sub>Cr</sub> (EX<sub>Cr</sub> T) to assess the adequacy of PD by creatinine clearance. All 166 patients had two EX<sub>Cr</sub> T determinations, 84 of the 166 patients had three EX<sub>Cr</sub> T determinations and 44 of the 166 patients had four EX<sub>Cr</sub> T measurements. EX<sub>Cr</sub> T values were compared using the paired <i>t</i> test in the patients who had two studies and by repeated measures ANOVA in those who were studied three or four times.</p><p><strong>Results: </strong>In patients who were studied twice, with the first and second EX<sub>Cr</sub> T measurements performed at 9.2 ± 15.2 mo and 17.4 ± 15.8 mo after onset of PD, respectively, EX<sub>Cr</sub> T did not differ between the first and second study. In patients studied three times and whose final assessment occurred 24.7 ± 16.3 mo after initiating PD, EX<sub>Cr</sub> T did not differ between the first and second study, but was significantly lower in the third study compared to the first study. In patients who were studied four times and whose fourth measurement was taken 31.9 ± 16.8 mo after onset of PD, EX<sub>Cr</sub> T did not differ between any of the studies. The average EX<sub>Cr</sub> T value did not change significantly, with the exception of the third study in the patients studied thrice. However, repeated determinations of EX<sub>Cr</sub> T in individuals showed substantial variability, with approximately 50% of the repeated determinations being higher or lower than the first determination by 15% or more.</p><p><strong>Conclusion: </strong>The average value of EX<sub>Cr</sub> T remains relatively constant for up to 2.5 years of follow-up in PD patients who adhere to the same PD schedule. However, repeated individual EX<sub>Cr</sub> T values vary considerably in a large proportion of the patients. Further studies are needed to evaluate the clinical significance of varying EX<sub>Cr</sub> T values and the stability of EX<sub>Cr</sub> T beyond 2.5 years of PD follow-up.</p>\",\"PeriodicalId\":23745,\"journal\":{\"name\":\"World Journal of Nephrology\",\"volume\":\"6 4\",\"pages\":\"201-208\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-07-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e6/c5/WJN-6-201.PMC5500457.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World Journal of Nephrology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5527/wjn.v6.i4.201\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Nephrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5527/wjn.v6.i4.201","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

目的:为了测试通过腹膜透析(PD)治疗的终末期肾病(ESKD)患者的肌酸酐排泄(EXCr)评估的肌肉质量是否维持,我们评估了PD人群中肌酸酐排泄(EXCr)的重复测量。方法:166名PD患者(94名男性,72名女性)在研究期间(长达约2.5年)接受相同PD剂量,反复测定总(尿液加透析液)24小时EXCr (EXCr T),通过肌酐清除率评估PD的充分性。所有166例患者均进行了两次EXCr T检测,166例患者中84例进行了三次EXCr T检测,166例患者中44例进行了四次EXCr T检测。在两次研究的患者中使用配对T检验比较EXCr T值,在研究三次或四次的患者中使用重复测量方差分析比较。结果:在两次研究的患者中,第一次和第二次EXCr T测量分别在PD发病后9.2±15.2个月和17.4±15.8个月进行,EXCr T在第一次和第二次研究中没有差异。在接受过三次研究且最终评估发生在PD开始后24.7±16.3个月的患者中,第一项研究和第二项研究的EXCr T没有差异,但第三项研究的EXCr T明显低于第一项研究。在研究了四次的患者中,第四次测量是在PD发病后31.9±16.8个月,任何研究之间的EXCr T没有差异。除了第三项研究中三次研究的患者外,平均EXCr T值没有显著变化。然而,在个体中重复测定EXCr T显示出很大的变异性,大约50%的重复测定比第一次测定高或低15%或更多。结论:在坚持相同PD计划的PD患者中,EXCr T的平均值在长达2.5年的随访中保持相对恒定。然而,重复的个体EXCr T值在很大一部分患者中差异很大。需要进一步的研究来评估不同的EXCr T值的临床意义以及超过2.5年PD随访的EXCr T的稳定性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Reproducibility of serial creatinine excretion measurements in peritoneal dialysis.

Aim: To test whether muscle mass evaluated by creatinine excretion (EXCr) is maintained in patients with end-stage kidney disease (ESKD) treated by peritoneal dialysis (PD), we evaluated repeated measurements of EXCr in a PD population.

Methods: One hundred and sixty-six PD patients (94 male, 72 female) receiving the same PD dose for the duration of the study (up to approximately 2.5 years) had repeated determinations of total (in urine plus spent dialysate) 24-h EXCr (EXCr T) to assess the adequacy of PD by creatinine clearance. All 166 patients had two EXCr T determinations, 84 of the 166 patients had three EXCr T determinations and 44 of the 166 patients had four EXCr T measurements. EXCr T values were compared using the paired t test in the patients who had two studies and by repeated measures ANOVA in those who were studied three or four times.

Results: In patients who were studied twice, with the first and second EXCr T measurements performed at 9.2 ± 15.2 mo and 17.4 ± 15.8 mo after onset of PD, respectively, EXCr T did not differ between the first and second study. In patients studied three times and whose final assessment occurred 24.7 ± 16.3 mo after initiating PD, EXCr T did not differ between the first and second study, but was significantly lower in the third study compared to the first study. In patients who were studied four times and whose fourth measurement was taken 31.9 ± 16.8 mo after onset of PD, EXCr T did not differ between any of the studies. The average EXCr T value did not change significantly, with the exception of the third study in the patients studied thrice. However, repeated determinations of EXCr T in individuals showed substantial variability, with approximately 50% of the repeated determinations being higher or lower than the first determination by 15% or more.

Conclusion: The average value of EXCr T remains relatively constant for up to 2.5 years of follow-up in PD patients who adhere to the same PD schedule. However, repeated individual EXCr T values vary considerably in a large proportion of the patients. Further studies are needed to evaluate the clinical significance of varying EXCr T values and the stability of EXCr T beyond 2.5 years of PD follow-up.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Antihypertensive prescribing patterns in non-dialysis dependent chronic kidney disease: Findings from the Salford Kidney Study Seeing through the myths: Practical aspects of diagnostic point-of-care ultrasound in nephrology Effectiveness and safety of apixaban and rivaroxaban vs warfarin in patients with atrial fibrillation and chronic kidney disease Heterogeneity in cardiorenal protection by Sodium glucose cotransporter 2 inhibitors in heart failure across the ejection fraction strata: Systematic review and meta-analysis Cryptococcosis in kidney transplant recipients: Current understanding and practices
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1